Delivery Order SPE2DB20D2104-SPE2DB23FV33D
- Not listed
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024, with a ceiling value of $2,176.55 and a completion date of December 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award is for SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, with a ceiling value of $2,608.14. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which covers a comprehensive...
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication, to the Defense Logistics Agency (DLA). The award, valued at $2,287.89, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 29, 2022 with a ceiling value of $1,239.33. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up...
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM pharmaceutical product to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,541.04, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 28, 2022. The contract has an ultimate completion date of September 29, 2022 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award....
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, with a ceiling value of $1,158.81. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical,...
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,849.56 and a completion date of August 4, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite...
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 22, 2023, with a completion date of November 24, 2023 and a ceiling value of $1,194.56. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,837.33 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has an ultimate completion date of September 15, 2023 and was made on September 14, 2023. The contract is a delivery order and does not have a set-aside designation, indicating open...
- This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,266.13, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 5, 2024. The award does not have a set-aside designation, indicating open...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FV33DDelivery Order
This federal contract award is for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,372.26 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/13/23 |